Universe Pharmaceuticals INC (NYSE:UPC – Get Free Report)’s stock price shot up 0.5% during mid-day trading on Tuesday . The company traded as high as $3.97 and last traded at $3.97. 26,211 shares traded hands during mid-day trading, a decline of 85% from the average session volume of 175,066 shares. The stock had previously closed at $3.95.
Universe Pharmaceuticals Stock Up 0.5%
The business has a 50 day simple moving average of $4.46 and a 200-day simple moving average of $13.32.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Universe Pharmaceuticals stock. Anson Funds Management LP acquired a new position in shares of Universe Pharmaceuticals INC (NYSE:UPC – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 230,407 shares of the company’s stock, valued at approximately $141,000. Anson Funds Management LP owned 13.40% of Universe Pharmaceuticals at the end of the most recent reporting period. Hedge funds and other institutional investors own 0.18% of the company’s stock.
About Universe Pharmaceuticals
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.
Recommended Stories
- Five stocks we like better than Universe Pharmaceuticals
- Retail Stocks Investing, Explained
- Analyst Downgrades Joby, But Overlooks Major Regulatory Wins
- What is the Nikkei 225 index?
- U.S. Steel Stock Burns the Bears With Surprise Upside Move
- The Risks of Owning Bonds
- Lululemon, UNH, Enphase: Bad News, Good Opportunity?
Receive News & Ratings for Universe Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universe Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.